• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Johnson & Johnson

Johnson & Johnson’s Cerenovus launches new clot removal devices to treat stroke

September 14, 2020 By Danielle Kirsh

Johnson & Johnson’s Cerenovus recently announced it has launched its new stroke solutions platform that includes three devices for clot removal procedures. The three devices are designed to aid physicians in performing mechanical thrombectomy procedures. The devices include the Cerebase DA Guide Sheath, Cerenovus Large Bore Catheter and Embotrap III Revascularization Device. Get the full […]

Filed Under: Catheters Tagged With: cerenovus, Johnson & Johnson

J&J’s Ethicon touts surgical stapler study

August 6, 2020 By Chris Newmarker

Ethicon — part of Johnson & Johnson (NYSE:JNJ) — is highlighting new study results in which its Echelon powered stapler with gripping surface technology (GST) had a lower rate of bleeding-related complications than a competing Medtronic product. Ethicon funded the peer-reviewed study, which appears online in Medical Devices: Evidence and Research. The study compared the Echelon […]

Filed Under: Surgical Tagged With: Ethicon, Johnson & Johnson, Medtronic

The most innovative pharmaceutical agents of 2020

August 3, 2020 By Danielle Kirsh

The Galien Foundation recently announced nominees for most innovative pharmaceutical agents for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical, pharmaceutical drugs and medical technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien process, […]

Filed Under: Cardiovascular, Featured, Neurological, Oncology, Pharmaceutical Tagged With: AbbVie, Adlon Therapeutics, Advanced Accelerator Applications, Astellas Pharma, Bayer, Eli Lilly & Co., Galien Foundation, Genentech, Greenwich Biosciences, GW Pharmaceuticals, Janssen Biotech, Johnson & Johnson, Karyopharm Therapeutics, Medicines Development for Global Health, Merck, Novartis, Pfizer, Population Council, Purdue Pharma, Roche Group, Servier Pharmaceuticals, SIGA Technologies, Sobi, TB Alliance, Theravance Biopharma

Johnson & Johnson to take its time on general surgery robot

July 17, 2020 By Chris Newmarker

Johnson & Johnson (NYSE:JNJ)  has decided not to follow a 510(k) clearance pathway for its planned general surgery robot — with a goal to start first-in-human studies with the system by the second half of 2022. That was one of the major pieces of information to come out of the New Brunswick, N.J.–based company’s quarterly earnings […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Robotics, Surgical Tagged With: Johnson & Johnson, Johnson and Johnson, robot-assisted, surgical robotics

Johnson & Johnson Q2 results beat The Street, medical device sales down a third

July 16, 2020 By Chris Newmarker

Johnson & Johnson (NYSE:JNJ) posted second-quarter results today that beat the consensus forecast on Wall Street — boosting its outlook for the year even as its medical device sales took a big hit from the COVID-19 pandemic. The New Brunswick, N.J.–based medical device and pharmaceutical giant reported profits of $3.6 billion, or $1.36 per share, on […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Johnson & Johnson

J&J accelerates development of its COVID-19 vaccine candidate

June 10, 2020 By Chris Newmarker

Johnson & Johnson (NYSE:JNJ) announced today that its Janssen Pharmaceutical subsidiary has moved up first-in-human clinical trials of its COVID-19 vaccine candidate to late July, versus the previously planned start in September. “Based on the strength of the preclinical data we have seen so far and interactions with the regulatory authorities, we have been able to […]

Filed Under: Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, Janssen Pharmaceuticals, Johnson & Johnson, Johnson and Johnson

J&J pledges $10m to fight racism in America

June 5, 2020 By Nancy Crotti

BD CEO also expresses “frustration, anger and dismay over the racial inequality and injustice.” Johnson & Johnson (NYSE:JNJ) this week pledged $10 million this week to fight racism and injustice in the U.S. In a response to the deaths of George Floyd in Minneapolis, Breonna Taylor in Louisville, Ky., and Ahmaud Arbery near Brunswick, Ga., J&J […]

Filed Under: Business/Financial News, Featured Tagged With: bectondickinson, Johnson & Johnson

AbbVie gains U.S. nod for $63B Allergan takeover

May 6, 2020 By Nancy Crotti

Pharmaceutical giant  AbbVie (NYSE:ABBV) has won U.S. antitrust approval for its  purchase of Allergan (NYSE:AGN) for $63 billion in cash and stock. The purchase is seen as a hedge against the impending expiration of U.S. patents on AbbVie’s blockbuster drug, Humira. North Chicago-based AbbVie announced the deal in June 2019, but ran up against U.S. […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Pharmaceutical, Wall Street Beat Tagged With: AbbVie, Allergan, AstraZeneca plc, Eli Lilly & Co., Federal Trade Commission (FTC), Johnson & Johnson

6 medtech execs join White House economic recovery group

April 15, 2020 By Nancy Crotti

Several medtech executives have been named to the White House task force designated by President Donald Trump to provide recommendations on how best to safely reopen the U.S. economy in the wake of the coronavirus  pandemic. The Great American Economic Revival healthcare industry group has 27 members, including: Mike Kauffman, CEO of Cardinal Health (NYSE:CAH). Brian […]

Filed Under: Business/Financial News Tagged With: 3m, Abbott, AdvaMed, coronavirus, COVID-19, Donald Trump, Johnson & Johnson, McKesson, Thermo Fisher Scientific

J&J beats The Street but lowers outlook for 2020

April 14, 2020 By Nancy Crotti

Johnson & Johnson (NYSE:JNJ) beat analysts’ expectations for sales and earnings in the first quarter of 2020, but lowered its financial outlook for the year due to the coronavirus pandemic. The New Brunswick, N.J.-based company reported profits of $6.154 billion, or $2.30 per share, on sales of $20.69 billion for the three months ended March 29, 2020, […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Pharmaceutical, Wall Street Beat Tagged With: coronavirus, COVID-19, Johnson & Johnson

How is coronavirus vaccine development going in the U.S.?

April 6, 2020 By Tom Salemi

Researchers in Pittsburgh and Boston are moving forward with research into two separate vaccine programs against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. The work of the University of Pittsburgh School of Medicine researchers is detailed in a paper published recently in EBioMedicine, which is published by the Lancet. Delivery of the vaccine involved a microneedle array to […]

Filed Under: Featured, News Well, Pharmaceutical Tagged With: Beth Israel Deaconess Medical Center, coronavirus, COVID-19, Janssen Pharmaceuticals, Johnson & Johnson, Johnson and Johnson, University of Pittsburgh

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS